This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


5wi0

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (14:13, 4 October 2023) (edit) (undo)
 
(2 intermediate revisions not shown.)
Line 1: Line 1:
==Crystal structure of human NAMPT with fragment 2: 2-[(2-fluorophenyl)amino]-6-propylpyrimidin-4(3H)-one==
==Crystal structure of human NAMPT with fragment 2: 2-[(2-fluorophenyl)amino]-6-propylpyrimidin-4(3H)-one==
-
<StructureSection load='5wi0' size='340' side='right' caption='[[5wi0]], [[Resolution|resolution]] 2.05&Aring;' scene=''>
+
<StructureSection load='5wi0' size='340' side='right'caption='[[5wi0]], [[Resolution|resolution]] 2.05&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[5wi0]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5WI0 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5WI0 FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[5wi0]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5WI0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5WI0 FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=AQ1:2-[(2-fluorophenyl)amino]-6-propylpyrimidin-4(3H)-one'>AQ1</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.05&#8491;</td></tr>
-
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Nicotinamide_phosphoribosyltransferase Nicotinamide phosphoribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.12 2.4.2.12] </span></td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=AQ1:2-[(2-fluorophenyl)amino]-6-propylpyrimidin-4(3H)-one'>AQ1</scene></td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5wi0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5wi0 OCA], [http://pdbe.org/5wi0 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5wi0 RCSB], [http://www.ebi.ac.uk/pdbsum/5wi0 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5wi0 ProSAT]</span></td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5wi0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5wi0 OCA], [https://pdbe.org/5wi0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5wi0 RCSB], [https://www.ebi.ac.uk/pdbsum/5wi0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5wi0 ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
-
[[http://www.uniprot.org/uniprot/NAMPT_HUMAN NAMPT_HUMAN]] Catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway (By similarity).
+
[https://www.uniprot.org/uniprot/NAMPT_HUMAN NAMPT_HUMAN] Catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway (By similarity).
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 19: Line 19:
</div>
</div>
<div class="pdbe-citations 5wi0" style="background-color:#fffaf0;"></div>
<div class="pdbe-citations 5wi0" style="background-color:#fffaf0;"></div>
 +
 +
==See Also==
 +
*[[Phosphoribosyltransferase 3D structures|Phosphoribosyltransferase 3D structures]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Nicotinamide phosphoribosyltransferase]]
+
[[Category: Homo sapiens]]
-
[[Category: Korepanova, A V]]
+
[[Category: Large Structures]]
-
[[Category: Longenecker, K L]]
+
[[Category: Korepanova AV]]
-
[[Category: Raich, D]]
+
[[Category: Longenecker KL]]
-
[[Category: Inhibitor]]
+
[[Category: Raich D]]
-
[[Category: Nampt]]
+
-
[[Category: Transferase]]
+
-
[[Category: Transferase-transferase inhibitor complex]]
+

Current revision

Crystal structure of human NAMPT with fragment 2: 2-[(2-fluorophenyl)amino]-6-propylpyrimidin-4(3H)-one

PDB ID 5wi0

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/5wi0"
Personal tools